Skip to main content
. 2017 Aug 25;7:9409. doi: 10.1038/s41598-017-09797-8

Figure 1.

Figure 1

Treatment with Sofosbuvir increases survival and inhibits weight loss of ZIKV-infected mice. Three-day-old Swiss mice were infected with ZIKV (2 × 107 PFU) and treated with sofosbuvir either 1 day before (A and B) or 2 days after infection (C and D). Survival (A and C) and weight variation (B and D) were assessed during the course of treatment (7 days). The red arrow indicates when animals were infected. Survival was statistically assessed by Log-rank (Mentel-Cox) test. Differences in weight are displayed as the means ± SEM, and two-way ANOVA for each day was used to assess the significance. Independent experiments were performed with at least 10 mice/group (n = 50). *P < 0.01; **P < 0.001.